Home | News | Find a Doctor | Ask a Question | Free

Histogen\'s next trial is funded by Singapore investors


#1

It seems that US investors didn’t want to help. What a shame. Histogen had to go to Singapore for help. Thanks “TE” for the info.

TE

6/17/10 11:12 pm

Whoop – Histogen was subjected to a lawsuit for copyright infringement (for a product that Histogen had not brought to market) no further news has been provided about the lawsuit (if anyone knows anything further I would love to hear it). The lawsuit did, however, result in a loss of funding by investors in the United States. Histogen then found some investors in Singapore – and, as a precondition to the investment, are continuing their phase II trials there (Singapore). The advantage of the trials overseas include a reduced time to come to market (no FDA approval required) while maintaining a strict adherence to trial standards that meet US criteria. If successful, Histogen will continue phase III in Asia and launch their product in that market (except for Japan). I think Histogen is making the best of a difficult situation and, hopefully, we will hear some good news soon.


#2

» It seems that US investors didn’t want to help. What a shame. Histogen had
» to go to Singapore for help. Thanks “TE” for the info.
»

Yes, thanks “TE” for this speculation - as I can find them en masse on hair loss boards …


#3

I know a guy that knows a guy who has a friend that knows a guy that says that’s hearsay.

» It seems that US investors didn’t want to help. What a shame. Histogen had
» to go to Singapore for help. Thanks “TE” for the info.
»
» http://www.xconomy.com/boston/2010/01/22/a-very-brief-follica-update-for-our-loyal-readers/
»
» # TE
» 6/17/10 11:12 pm
»
» Whoop – Histogen was subjected to a lawsuit for copyright infringement
» (for a product that Histogen had not brought to market) no further news has
» been provided about the lawsuit (if anyone knows anything further I would
» love to hear it). The lawsuit did, however, result in a loss of funding by
» investors in the United States. Histogen then found some investors in
» Singapore – and, as a precondition to the investment, are continuing their
» phase II trials there (Singapore). The advantage of the trials overseas
» include a reduced time to come to market (no FDA approval required) while
» maintaining a strict adherence to trial standards that meet US criteria. If
» successful, Histogen will continue phase III in Asia and launch their
» product in that market (except for Japan). I think Histogen is making the
» best of a difficult situation and, hopefully, we will hear some good news
» soon.


#4

» I know a guy that knows a guy who has a friend that knows a guy that says
» that’s hearsay.
»
»
»
» » It seems that US investors didn’t want to help. What a shame. Histogen
» had
» » to go to Singapore for help. Thanks “TE” for the info.
» »
» »
» http://www.xconomy.com/boston/2010/01/22/a-very-brief-follica-update-for-our-loyal-readers/
» »
» » # TE
» » 6/17/10 11:12 pm
» »
» » Whoop – Histogen was subjected to a lawsuit for copyright infringement
» » (for a product that Histogen had not brought to market) no further news
» has
» » been provided about the lawsuit (if anyone knows anything further I
» would
» » love to hear it). The lawsuit did, however, result in a loss of funding
» by
» » investors in the United States. Histogen then found some investors in
» » Singapore – and, as a precondition to the investment, are continuing
» their
» » phase II trials there (Singapore). The advantage of the trials overseas
» » include a reduced time to come to market (no FDA approval required)
» while
» » maintaining a strict adherence to trial standards that meet US criteria.
» If
» » successful, Histogen will continue phase III in Asia and launch their
» » product in that market (except for Japan). I think Histogen is making
» the
» » best of a difficult situation and, hopefully, we will hear some good
» news
» » soon.

BTW ITS NOT ABOUT HISTOGEN ITS ABOUT FOLLICA.

Why the heck did spanish dude use Histogen in his subject:-D


#5

» BTW ITS NOT ABOUT HISTOGEN ITS ABOUT FOLLICA.
»
» Why the heck did spanish dude use Histogen in his subject:-D

Oh, and I thought it’s about a new attack against his friend Dr. Gho … :expressionless:


#6

» BTW ITS NOT ABOUT HISTOGEN ITS ABOUT FOLLICA.
»
» Why the heck did spanish dude use Histogen in his subject:-D

Jesus Christ, what have I done to deserve this?? :crying:


#7

» I know a guy that knows a guy who has a friend that knows a guy that says
» that’s hearsay.

Could be hearsay, but it doesn’t look like it.
Do you know if this is false?


#8

Link provided by Leeroy.Jenkins:
http://lifestyletom.com/path/rao10925685692ros/roin59012264499

<<<<
Histogen Announces Initial Close of Series A Financing Round

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the initial close of Series A financing at $5.35 million. The round was completed by private and corporate investors, including Secure Medical Inc., CellCeuticals Skin Care Inc., and Leonard H. Lavin, founder and Chairman Emeritus of the Alberto-Culver Company.
<<<<

These are all american investors.

» It seems that US investors didn’t want to help. What a shame. Histogen had
» to go to Singapore for help. Thanks “TE” for the info.
»
» http://www.xconomy.com/boston/2010/01/22/a-very-brief-follica-update-for-our-loyal-readers/
»
» # TE
» 6/17/10 11:12 pm
»
» Whoop – Histogen was subjected to a lawsuit for copyright infringement
» (for a product that Histogen had not brought to market) no further news has
» been provided about the lawsuit (if anyone knows anything further I would
» love to hear it). The lawsuit did, however, result in a loss of funding by
» investors in the United States. Histogen then found some investors in
» Singapore – and, as a precondition to the investment, are continuing their
» phase II trials there (Singapore). The advantage of the trials overseas
» include a reduced time to come to market (no FDA approval required) while
» maintaining a strict adherence to trial standards that meet US criteria. If
» successful, Histogen will continue phase III in Asia and launch their
» product in that market (except for Japan). I think Histogen is making the
» best of a difficult situation and, hopefully, we will hear some good news
» soon.


#9

» Link provided by Leeroy.Jenkins:
» http://lifestyletom.com/path/rao10925685692ros/roin59012264499
»
» <<<<
» Histogen Announces Initial Close of Series A Financing Round
»
» Histogen, Inc., a regenerative medicine company developing solutions based
» on the products of newborn fibroblasts, today announced the initial close
» of Series A financing at $5.35 million. The round was completed by private
» and corporate investors, including Secure Medical Inc., CellCeuticals
» Skin Care Inc., and Leonard H. Lavin, founder and Chairman Emeritus of the
» Alberto-Culver Company.

» <<<<
»
» These are all american investors.
»
»
» » It seems that US investors didn’t want to help. What a shame. Histogen
» had
» » to go to Singapore for help. Thanks “TE” for the info.
» »
» »
» http://www.xconomy.com/boston/2010/01/22/a-very-brief-follica-update-for-our-loyal-readers/
» »
» » # TE
» » 6/17/10 11:12 pm
» »
» » Whoop – Histogen was subjected to a lawsuit for copyright infringement
» » (for a product that Histogen had not brought to market) no further news
» has
» » been provided about the lawsuit (if anyone knows anything further I
» would
» » love to hear it). The lawsuit did, however, result in a loss of funding
» by
» » investors in the United States. Histogen then found some investors in
» » Singapore – and, as a precondition to the investment, are continuing
» their
» » phase II trials there (Singapore). The advantage of the trials overseas
» » include a reduced time to come to market (no FDA approval required)
» while
» » maintaining a strict adherence to trial standards that meet US criteria.
» If
» » successful, Histogen will continue phase III in Asia and launch their
» » product in that market (except for Japan). I think Histogen is making
» the
» » best of a difficult situation and, hopefully, we will hear some good
» news
» » soon.

Whats Wrong Spanish Dude you gave this TE Guy applause and now you doubt what he was saying. You know first i wanted to say something about singapure investements but i let it slip because i dont want another useless discussion.

Even if you dont like Iron Man, he would never never never never (as far as i saw this here) talk such a bullcrap like this TE guy and his singapure investors.

Spanish Dude know your enemies thats all iam saying and thats the reason why i send this link here without any comments.


#10

» Whats Wrong Spanish Dude you gave this TE Guy applause and now you doubt
» what he was saying. You know first i wanted to say something about
» singapure investements but i let it slip because i dont want another
» useless discussion.
»
» Even if you dont like Iron Man, he would never never never never (as far
» as i saw this here) talk such a bullcrap like this TE guy and his singapure
» investors.
»
» Spanish Dude know your enemies thats all iam saying and thats the reason
» why i send this link here without any comments.

Calm down.

First time I know a person, in this case TE, I give him/her the benefit of the doubt. If later I find out that this person is not reliable, or is a troll, etc, I will treat him/her accordingly.

Even though the list of investors is not complete, It seems that TE was indeed incorrect/wrong. TE was also wrong when he said, in xconomy, that Histogen had started the Singapore trials in June. He later appologize for this mistake (June was the initial plan, but later was delayed to Feb-2011).

So, from now on, TE will have to be more careful, and we will also have to be more careful with his informations.

On my own part, I think I have done the correct think updating this thread to alert on a possible mistake.


#11

And here the (tediously BS) story in full …

» » » Hi Spanish Dude - I’m the fellow (TE) who posted on Follica that
» Histogen
» » was now being funded by investors from Singapore - (with my knowledge
» being
» » a very qualified secondary source) - I was also attacked by this ‘iron
» man’
» » - he seems very angry - as well as suffering from low self-esteem. I
» wish
» » him well, however, with his condition.
» -----------
[Spanish Dude - 22.07.2010, 15:54]:
» Thanks TE for your input!
» I gave credibility to your info, because it makes no sense that someone
» invents such kind of lie.
» Anyway, in this crazy world of Hairloss, everything is possible.
» Yes, Iron_Man has very rough manners. All his kindness is reserved
» exclusively to Gho, Hitzig and Cooley. :slight_smile:
Source: http://www.hairsite.com/hair-loss/forum_entry-id-70628-page-0-category-1-order-last_answer.html

Leeroy.Jenkins:
» » Whats Wrong Spanish Dude you gave this TE Guy applause and now you doubt
» » what he was saying. You know first i wanted to say something about
» » singapure investements but i let it slip because i dont want another
» » useless discussion.
» »
» » Even if you dont like Iron Man, he would never never never never (as
» far
» » as i saw this here) talk such a bullcrap like this TE guy and his
» singapure
» » investors.
» »
» » Spanish Dude know your enemies thats all iam saying and thats the
» reason
» » why i send this link here without any comments.
» ---------------
[Spanish Dude - 23.07.2010, 08:16]:
» Calm down.
»
» First time I know a person, in this case TE, I give him/her the benefit of
» the doubt. If later I find out that this person is not reliable, or is a
» troll, etc, I will treat him/her accordingly.
»
» Even though the list of investors is not complete, It seems that TE was
» indeed incorrect/wrong. TE was also wrong when he said, in xconomy, that
» Histogen had started the Singapore trials in June. He later appologize for
» this mistake (June was the initial plan, but later was delayed to
» Feb-2011).
»
» So, from now on, TE will have to be more careful, and we will also have to
» be more careful with his informations.
»
» On my own part, I think I have done the correct think updating this thread
» to alert on a possible mistake.

The whole thread is FULL of Bullsh’t and bla bla bla - produced by a Dude from Spain.


#12

And thats the reason why i think that Iron Man is indeed an assett to this site.

“Secondary Sources” well this is like those urban Legends.

And to claim that there are singapor investors wow this is a tough one because the asian market has their own ARI and Histogens.

BTW just to lighten things up a little, i can guanrantee you that almost every country or nation has their own HM Researchers :slight_smile:


#13

Okay, after about 5 years reading here I’m well and truly fed up with this forums lack of moderation and incessant bickering. Does anyone know a good site that is actually moderated and contains information rather than the crap that is all over this board?


#14

I agree with TylerDurden, this forum is becoming cluttered with the bickering and vulgar bitching of 3 to 4 members. LeeroyJ, Iron_Man, Spanish for goodness sake tone it down!!!


#15

» I agree with TylerDurden, this forum is becoming cluttered with the
» bickering and vulgar bitching of 3 to 4 members. LeeroyJ, Iron_Man, Spanish
» for goodness sake tone it down!!!

Bla bla bla dont destroy this thread here we are gathering serious informations and to clear up rumors.

Its really getting old


#16

Yeah, we are waiting to see what TE has to say.
Sometimes it is interesting to listen to “non-standard sources”, even if they are “risky”. For example, Bald-Half Truth is providing interesting info.

» Bla bla bla dont destroy this thread here we are gathering serious
» informations and to clear up rumors.
»
» Its really getting old


#17

The best source of news that I have been able to glean comes by requesting updated information from the principles (ie: the company representatives or marketing dept’s). I have requested information directly from Eileen Naughton Brand, Director of Corporate Communications, Histogen Inc. for most of my Histogen related enquiries. I have shared this information with others and, subsequently, have been ‘attacked’ by citing it. Many of the blog sites are populated by people who do not use due diligence or discipline in approaching the subject. The best general site I have found is a follica blog but even there you have to filter the information. It’s probably best to use your own initiative and keep your own council. I did indeed make the mistake of saying that Histogen had begun it’s trials in Singapore when they had not done so (it was based on an interview with Dr. Naughton who cited the specific date I used in the thread). I have since apologized for the error and it was not my intention to mislead anyone.

PS: It is true that series A funding for Histogen was provided by American investors - this money was being used up by the initial trials and general expenses, salaries etc. (called “burn-rate” by investors). Series B, however, was about to be funded in America but the investors backed out once the lawsuit was announced. Histogen then had a general meeting among the staff - and explained the situation. Most of the staff elected to continue with the company despite the fear that they may not be paid. Series B funding was then provided by Singaporean investors with the caveat/precondition that the trials take place in their country. Singapore is currently a hotbed for this type of research and extends to their business people very good tax incentives to develop this market further.

In the future I will take my own advice (keep my own council) and make no further postings on this subject.

TE


#18

» The best source of news that I have been able to glean comes by requesting
» updated information from the principles (ie: the company representatives or
» marketing dept’s). I have requested information directly from Eileen
» Naughton Brand, Director of Corporate Communications, Histogen Inc. for
» most of my Histogen related enquiries. I have shared this information with
» others and, subsequently, have been ‘attacked’ by citing it. Many of the
» blog sites are populated by people who do not use due diligence or
» discipline in approaching the subject. The best general site I have found
» is a follica blog but even there you have to filter the information. It’s
» probably best to use your own initiative and keep your own council. I did
» indeed make the mistake of saying that Histogen had begun it’s trials in
» Singapore when they had not done so (it was based on an interview with Dr.
» Naughton who cited the specific date I used in the thread). I have since
» apologized for the error and it was not my intention to mislead anyone.
»
» PS: It is true that series A funding for Histogen was provided by American
» investors - this money was being used up by the initial trials and general
» expenses, salaries etc. (called “burn-rate” by investors). Series B,
» however, was about to be funded in America but the investors backed out
» once the lawsuit was announced. Histogen then had a general meeting among
» the staff - and explained the situation. Most of the staff elected to
» continue with the company despite the fear that they may not be paid.

» Series B funding was then provided by Singaporean investors with the
» caveat/precondition that the trials take place in their country. Singapore
» is currently a hotbed for this type of research and extends to their
» business people very good tax incentives to develop this market further.
»
» In the future I will take my own advice (keep my own council) and make no
» further postings on this subject.
»
» TE

And now the big question “Why did the choose to stay” hmmm someone wanna give an answer :wink:


#19

Okay, there has been a mistake. Sorry, TE, you are probably right about Singapore investors funding Series B.

Leeroy posted a link
http://lifestyletom.com/path/rao10925685692ros/roin59012264499

This article is about Series A funding. Leeroy posted it as breaking news (probably because the date shown in the article is the current date, not the article’s date), but this piece of news is, in fact, 2 years old (dates May,02, 2008) and it is listed on Histogen’s website:
http://www.histogen.com/aboutus/news_events.htm

This Series A was indeed funded by American investors, but the current funding round is Series B, and foum member ET could be right when he says this is being funded by Singapore investors.

Sorry, TE, at the time, I was not well informed about these “funding rounds” so I thought Series A was the latest one. I should have verified the date of the article.

» Link provided by Leeroy.Jenkins:
»
»
» <<<<
» Histogen Announces Initial Close of Series A Financing Round
»
» Histogen, Inc., a regenerative medicine company developing solutions based
» on the products of newborn fibroblasts, today announced the initial close
» of Series A financing at $5.35 million. The round was completed by private
» and corporate investors, including Secure Medical Inc., CellCeuticals
» Skin Care Inc., and Leonard H. Lavin, founder and Chairman Emeritus of the
» Alberto-Culver Company.

» <<<<
»
» These are all american investors.
»
»
» » It seems that US investors didn’t want to help. What a shame. Histogen
» had
» » to go to Singapore for help. Thanks “TE” for the info.
» »
» »
» http://www.xconomy.com/boston/2010/01/22/a-very-brief-follica-update-for-our-loyal-readers/
» »
» » # TE
» » 6/17/10 11:12 pm
» »
» » Whoop – Histogen was subjected to a lawsuit for copyright infringement
» » (for a product that Histogen had not brought to market) no further news
» has
» » been provided about the lawsuit (if anyone knows anything further I
» would
» » love to hear it). The lawsuit did, however, result in a loss of funding
» by
» » investors in the United States. Histogen then found some investors in
» » Singapore – and, as a precondition to the investment, are continuing
» their
» » phase II trials there (Singapore). The advantage of the trials overseas
» » include a reduced time to come to market (no FDA approval required)
» while
» » maintaining a strict adherence to trial standards that meet US criteria.
» If
» » successful, Histogen will continue phase III in Asia and launch their
» » product in that market (except for Japan). I think Histogen is making
» the
» » best of a difficult situation and, hopefully, we will hear some good
» news
» » soon.


#20

Hello TE, my appologies.

The article posted by Leeroy.Jenkins has a wrong date, and appears with a recent date, when in fact is 2 year old.

As you say, Series A was closed 2 years ago, so it doesn’t belong to our discussion.

You might be right about the Series B being raised from Singapore investors.

» The best source of news that I have been able to glean comes by requesting
» updated information from the principles (ie: the company representatives or
» marketing dept’s). I have requested information directly from Eileen
» Naughton Brand, Director of Corporate Communications, Histogen Inc. for
» most of my Histogen related enquiries. I have shared this information with
» others and, subsequently, have been ‘attacked’ by citing it. Many of the
» blog sites are populated by people who do not use due diligence or
» discipline in approaching the subject. The best general site I have found
» is a follica blog but even there you have to filter the information. It’s
» probably best to use your own initiative and keep your own council. I did
» indeed make the mistake of saying that Histogen had begun it’s trials in
» Singapore when they had not done so (it was based on an interview with Dr.
» Naughton who cited the specific date I used in the thread). I have since
» apologized for the error and it was not my intention to mislead anyone.
»
» PS: It is true that series A funding for Histogen was provided by American
» investors - this money was being used up by the initial trials and general
» expenses, salaries etc. (called “burn-rate” by investors). Series B,
» however, was about to be funded in America but the investors backed out
» once the lawsuit was announced. Histogen then had a general meeting among
» the staff - and explained the situation. Most of the staff elected to
» continue with the company despite the fear that they may not be paid.
» Series B funding was then provided by Singaporean investors with the
» caveat/precondition that the trials take place in their country. Singapore
» is currently a hotbed for this type of research and extends to their
» business people very good tax incentives to develop this market further.
»
» In the future I will take my own advice (keep my own council) and make no
» further postings on this subject.
»
» TE